Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.05
NYSE:THC's Cash to Debt is ranked lower than
85% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 0.32 vs. NYSE:THC: 0.05 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:THC' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: 0.35
Current: 0.05
0
0.35
Equity to Asset 0.02
NYSE:THC's Equity to Asset is ranked lower than
93% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. NYSE:THC: 0.02 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:THC' s Equity to Asset Range Over the Past 10 Years
Min: 0  Med: 0.17 Max: 0.43
Current: 0.02
0
0.43
Interest Coverage 1.29
NYSE:THC's Interest Coverage is ranked lower than
90% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 7.01 vs. NYSE:THC: 1.29 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:THC' s Interest Coverage Range Over the Past 10 Years
Min: 0.66  Med: 1.23 Max: 1.82
Current: 1.29
0.66
1.82
F-Score: 4
Z-Score: 0.95
WACC vs ROIC
4.66%
7.81%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 6.38
NYSE:THC's Operating margin (%) is ranked lower than
52% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 6.81 vs. NYSE:THC: 6.38 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:THC' s Operating margin (%) Range Over the Past 10 Years
Min: -8.66  Med: 5.82 Max: 8.21
Current: 6.38
-8.66
8.21
Net-margin (%) -1.06
NYSE:THC's Net-margin (%) is ranked lower than
77% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. NYSE:THC: -1.06 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:THC' s Net-margin (%) Range Over the Past 10 Years
Min: -9.5  Med: 0.18 Max: 13.5
Current: -1.06
-9.5
13.5
ROE (%) -33.13
NYSE:THC's ROE (%) is ranked lower than
93% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 9.71 vs. NYSE:THC: -33.13 )
Ranked among companies with meaningful ROE (%) only.
NYSE:THC' s ROE (%) Range Over the Past 10 Years
Min: -124.98  Med: 2.68 Max: 92.79
Current: -33.13
-124.98
92.79
ROA (%) -0.88
NYSE:THC's ROA (%) is ranked lower than
77% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. NYSE:THC: -0.88 )
Ranked among companies with meaningful ROA (%) only.
NYSE:THC' s ROA (%) Range Over the Past 10 Years
Min: -8.75  Med: 0.19 Max: 13.89
Current: -0.88
-8.75
13.89
ROC (Joel Greenblatt) (%) 15.00
NYSE:THC's ROC (Joel Greenblatt) (%) is ranked lower than
56% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 18.74 vs. NYSE:THC: 15.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:THC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -14.52  Med: 10.95 Max: 15.25
Current: 15
-14.52
15.25
Revenue Growth (3Y)(%) 30.90
NYSE:THC's Revenue Growth (3Y)(%) is ranked higher than
95% of the 181 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. NYSE:THC: 30.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:THC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -13.7  Med: -0.2 Max: 32.4
Current: 30.9
-13.7
32.4
EBITDA Growth (3Y)(%) 20.10
NYSE:THC's EBITDA Growth (3Y)(%) is ranked higher than
75% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 7.40 vs. NYSE:THC: 20.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:THC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.1  Med: 7.7 Max: 31.5
Current: 20.1
-47.1
31.5
» NYSE:THC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

THC Guru Trades in Q4 2015

Louis Moore Bacon 40,156 sh (New)
Paul Tudor Jones 13,400 sh (+139.29%)
Larry Robbins 17,890,230 sh (+8.49%)
Mario Gabelli 15,040 sh (unchged)
Steven Cohen 150,000 sh (unchged)
Jim Simons Sold Out
Ray Dalio Sold Out
Steven Cohen Sold Out
» More
Q1 2016

THC Guru Trades in Q1 2016

David Tepper 348,405 sh (New)
George Soros 31,700 sh (New)
Mario Gabelli 15,050 sh (+0.07%)
Larry Robbins 17,890,230 sh (unchged)
Paul Tudor Jones Sold Out
Louis Moore Bacon Sold Out
» More
Q2 2016

THC Guru Trades in Q2 2016

Joel Greenblatt 545,902 sh (New)
Larry Robbins 17,890,230 sh (unchged)
George Soros Sold Out
David Tepper Sold Out
Mario Gabelli 15,000 sh (-0.33%)
» More
Q3 2016

THC Guru Trades in Q3 2016

Steven Cohen 415,400 sh (New)
Paul Tudor Jones 45,786 sh (New)
Larry Robbins 17,890,230 sh (unchged)
Mario Gabelli 15,000 sh (unchged)
Joel Greenblatt 22,489 sh (-95.88%)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:AMN, NYSE:SEM, NAS:SCAI, NAS:AMED, NAS:PAHC, NAS:LPNT, OTCPK:LTGHY, NAS:HWAY, NYSE:CHE, NAS:LHCG, NAS:SGRY, NYSE:USPH, NYSE:CYH, OTCPK:RLGHF, NAS:PRSC, NAS:AFAM, OTCPK:MFCSF, NAS:ADUS, OTCPK:CMBGF, NAS:USMD » details
Traded in other countries:THC1.Germany,
Tenet Healthcare Corp is a health care services company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks.

Tenet Healthcare Corp, a Nevada corporation was incorporated in 1975. It is an investor-owned company whose subsidiaries and affiliates operate regionally health care delivery networks with a presence in several urban and suburban markets. At the core of its networks are acute care and specialty hospitals that, together with its strategically aligned outpatient facilities and related businesses, allow them to provide a comprehensive range of health care services in the communities it serves. The Company operated 86 hospitals, 475 outpatient centers, six health plans, six accountable care networks and Conifer Health Solutions, LLC ("Conifer"), which provides business process solutions to more than 700 hospital and other clients nationwide. It provides comprehensive operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. It also offers communications and engagement solutions to optimize the relationship between providers and patients. In addition, its management services offerings have expanded to support value-based performance through clinical integration, financial risk management and population health management. For financial reporting purposes, its business lines are classified into two separate reportable business segments - hospital operations and other, and Conifer. Its subsidiaries operated 86 hospitals, including four academic medical centers, two children's hospitals, three specialty hospitals and a critical access hospital, with a total of 22,525 licensed beds, serving urban and suburban communities in 14 states. Of those hospitals, 67 were owned by its subsidiaries, and five were owned by third parties and leased by its subsidiaries. In addition, its subsidiaries operated a long-term acute care hospital and owned or leased and operated a number of medical office buildings, all of which were located on, or nearby, its hospital campuses. The Company also owns or controls six accountable care networks - in Florida, California, Illinois, Michigan and Texas - and participates in two additional accountable care networks through collaborations with other health care providers in its markets in Arizona and Massachusetts. These networks operate using a range of payment and delivery models that seek to align provider reimbursement in a way that encourages improved quality metrics and efficiencies in the total cost of care for an assigned population of patients through cooperation of the providers. The Company's health plans are subject to state and federal laws and regulations. Both federal and state government agencies continue heightened and coordinated civil and criminal enforcement efforts against the health care industry.

Top Ranked Articles about Tenet Healthcare Corp

Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Robbins increased his stake in insurance company Humana
Guru Larry Robbins (Trades, Portfolio), the founder and CEO of Glenview Capital Management, also serves on the Robin Hood Foundation Board of Directors, as well as the board for Teach for America. Read more...

Ratios

vs
industry
vs
history
Forward P/E 6.54
THC's Forward P/E is ranked higher than
95% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 18.15 vs. THC: 6.54 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 2.84
THC's P/B is ranked lower than
58% of the 284 Companies
in the Global Medical Care industry.

( Industry Median: 2.59 vs. THC: 2.84 )
Ranked among companies with meaningful P/B only.
THC' s P/B Range Over the Past 10 Years
Min: 1.39  Med: 5.23 Max: 100.25
Current: 2.84
1.39
100.25
P/S 0.08
THC's P/S is ranked higher than
98% of the 281 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. THC: 0.08 )
Ranked among companies with meaningful P/S only.
THC' s P/S Range Over the Past 10 Years
Min: 0.05  Med: 0.31 Max: 0.56
Current: 0.08
0.05
0.56
PFCF 2.13
THC's PFCF is ranked higher than
99% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 23.98 vs. THC: 2.13 )
Ranked among companies with meaningful PFCF only.
THC' s PFCF Range Over the Past 10 Years
Min: 2.06  Med: 40.45 Max: 514.15
Current: 2.13
2.06
514.15
POCF 1.43
THC's POCF is ranked higher than
99% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 14.06 vs. THC: 1.43 )
Ranked among companies with meaningful POCF only.
THC' s POCF Range Over the Past 10 Years
Min: 1.31  Med: 6.51 Max: 15.63
Current: 1.43
1.31
15.63
EV-to-EBIT 12.65
THC's EV-to-EBIT is ranked higher than
76% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 19.73 vs. THC: 12.65 )
Ranked among companies with meaningful EV-to-EBIT only.
THC' s EV-to-EBIT Range Over the Past 10 Years
Min: -273.8  Med: 13.8 Max: 1337.9
Current: 12.65
-273.8
1337.9
EV-to-EBITDA 7.60
THC's EV-to-EBITDA is ranked higher than
88% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 14.47 vs. THC: 7.60 )
Ranked among companies with meaningful EV-to-EBITDA only.
THC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -34  Med: 8.25 Max: 22.6
Current: 7.6
-34
22.6
Shiller P/E 35.76
THC's Shiller P/E is ranked lower than
64% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 27.79 vs. THC: 35.76 )
Ranked among companies with meaningful Shiller P/E only.
THC' s Shiller P/E Range Over the Past 10 Years
Min: 34.64  Med: 82.28 Max: 301.91
Current: 35.76
34.64
301.91
Current Ratio 1.13
THC's Current Ratio is ranked lower than
57% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. THC: 1.13 )
Ranked among companies with meaningful Current Ratio only.
THC' s Current Ratio Range Over the Past 10 Years
Min: 1.13  Med: 1.52 Max: 2.38
Current: 1.13
1.13
2.38
Quick Ratio 1.05
THC's Quick Ratio is ranked lower than
56% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. THC: 1.05 )
Ranked among companies with meaningful Quick Ratio only.
THC' s Quick Ratio Range Over the Past 10 Years
Min: 1.05  Med: 1.42 Max: 2.29
Current: 1.05
1.05
2.29
Days Inventory 8.86
THC's Days Inventory is ranked higher than
73% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 18.12 vs. THC: 8.86 )
Ranked among companies with meaningful Days Inventory only.
THC' s Days Inventory Range Over the Past 10 Years
Min: 8.92  Med: 10.48 Max: 13.35
Current: 8.86
8.92
13.35
Days Sales Outstanding 51.39
THC's Days Sales Outstanding is ranked lower than
61% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 42.08 vs. THC: 51.39 )
Ranked among companies with meaningful Days Sales Outstanding only.
THC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.89  Med: 53.87 Max: 67
Current: 51.39
46.89
67
Days Payable 35.45
THC's Days Payable is ranked lower than
53% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 38.52 vs. THC: 35.45 )
Ranked among companies with meaningful Days Payable only.
THC' s Days Payable Range Over the Past 10 Years
Min: 40.4  Med: 48.85 Max: 56.74
Current: 35.45
40.4
56.74

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 2.00
THC's 3-Year Average Share Buyback Ratio is ranked higher than
87% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. THC: 2.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
THC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -12.9  Med: -0.5 Max: 7.3
Current: 2
-12.9
7.3

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.68
THC's Price/Projected FCF is ranked higher than
88% of the 115 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. THC: 0.68 )
Ranked among companies with meaningful Price/Projected FCF only.
THC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.67  Med: 1.17 Max: 130.86
Current: 0.68
0.67
130.86
Price/Median PS Value 0.25
THC's Price/Median PS Value is ranked higher than
97% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 1.00 vs. THC: 0.25 )
Ranked among companies with meaningful Price/Median PS Value only.
THC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.21  Med: 1.42 Max: 5.79
Current: 0.25
0.21
5.79
Earnings Yield (Greenblatt) (%) 7.90
THC's Earnings Yield (Greenblatt) (%) is ranked higher than
80% of the 295 Companies
in the Global Medical Care industry.

( Industry Median: 4.17 vs. THC: 7.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
THC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.1  Med: 6.6 Max: 15.7
Current: 7.9
0.1
15.7
Forward Rate of Return (Yacktman) (%) 37.80
THC's Forward Rate of Return (Yacktman) (%) is ranked higher than
94% of the 110 Companies
in the Global Medical Care industry.

( Industry Median: 10.28 vs. THC: 37.80 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
THC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -103.1  Med: 0.5 Max: 38.1
Current: 37.8
-103.1
38.1

More Statistics

Revenue (TTM) (Mil) $19,787
EPS (TTM) $ -2.12
Beta0.90
Short Percentage of Float19.30%
52-Week Range $14.06 - 35.35
Shares Outstanding (Mil)99.64

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 19,590 19,913 21,085
EPS ($) 1.43 2.24 2.59
EPS w/o NRI ($) 1.43 2.24 2.59
EPS Growth Rate
(3Y to 5Y Estimate)
37.79%
Dividends Per Share ($)
» More Articles for THC

Headlines

Articles On GuruFocus.com
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Dec 06 2015 
Insiders Buy Stock in Wynn Resorts, Bank of New York Mellon Oct 25 2015 
Larry Robbins Raises Stake in Tenet Healthcare Oct 05 2015 
Obamacare Makes HCA a Buy Aug 24 2015 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Distressed Debt Investor Paul Singer Buys Citrix Systems Jun 11 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Tenet Healthcare And United Surgical JV For $1.93 Billion Mar 24 2015 
Mario Gabelli’s Equity Income Fund Q3 2014 Commentary Oct 29 2014 

More From Other Websites
Should You Avoid Graham Holdings Co (GHC)? Dec 02 2016
Tenet and UnitedHealthcare Renew National Relationship Dec 02 2016
4:45 pm Tenet Healthcare and UnitedHealthcare (UNH) renewed their... Dec 02 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Tenet Healthcare... Dec 02 2016
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of... Dec 02 2016
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tenet... Dec 02 2016
UPCOMING DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tenet... Dec 01 2016
Tenet Announces Completion of its Private Offering of Senior Secured Second Lien Notes Dec 01 2016
Tenet Announces Completion of its Private Offering of Senior Secured Second Lien Notes Dec 01 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Tenet Healthcare... Nov 30 2016
THC REMINDER: Rosen Law Firm Reminds Tenet Healthcare Corp. Investors of Important Deadline in... Nov 30 2016
APPROACHING DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Nov 29 2016
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tenet... Nov 29 2016
Is Ellie Mae Inc (ELLI) A Good Stock To Buy? Nov 29 2016
Is Monolithic Power Systems, Inc. (MPWR) A Good Stock To Buy? Nov 28 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Tenet Healthcare... Nov 28 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tenet... Nov 28 2016
UPCOMING DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tenet... Nov 28 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tenet Healthcare Corp. of a Class... Nov 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)